Search | Page 6 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS)

    ... research study is to compare how 2 different drugs, decitabine and azacitidine , when given on a shorter than standard ... Azacitidine Decitabine Phase:  ...

    Clinical Trial last updated 05/14/2018 - 1:55pm.

  2. A Phase II Study of SGI-110 in Philadelphia-Negative Myeloproliferative Neoplasms

    ... of similar chemical or biological composition to decitabine or SGI-110. Uncontrolled intercurrent illness including, but ...

    Clinical Trial last updated 05/14/2018 - 2:02pm.

  3. A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients with Myelodysplastic Syndrome (MDS)

    ... second generation compounds such as SGI-110, oral decitabine or oral azacitidine and will also include combinations with ...

    Clinical Trial last updated 05/14/2018 - 1:57pm.

  4. Patient Trusts Her Instincts in Finding the Right Treatment

    ... .”  When I first got to CTCA, I started on decitabine (Dacogen®) using a five day/1-hour infusion.  It dropped my ...

    Patient Chronicle last updated 05/10/2018 - 11:01am.

  5. A Remarkable Response in a Clinical Trial

    ... blood cell counts. My treatment at the beginning was decitabine (Dacogen®) for 5 days every 28 days. Then after seven months, I ...

    Patient Chronicle last updated 04/26/2018 - 12:46pm.

  6. Retired MDS Patient Living Life to the Fullest Since Transplant

    ... In February 2010, I started a five-day dose of decitabine (Dacogen®) and chemotherapy and also had the first of ...

    Patient Chronicle last updated 04/26/2018 - 10:43am.

  7. San Diego Family Takes Action for Awareness

    ... the three FDA approved drugs, azacitidine , decitabine , and lenalidomide – noting of course that the latter ...

    Patient Chronicle last updated 04/26/2018 - 9:33am.

  8. Selinexor (KPT-330) in Older Patients With Relapsed/Refractory AML (SOPRA)

    ... (i) BSC alone, (ii) BSC plus either azacytidine or decitabine or (iii) BSC plus low-dose Ara-C. Overall survival is the ... Azacitidine Decitabine Selinexor (KPT-330) ...

    Clinical Trial last updated 04/17/2018 - 1:51pm.

  9. Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10-day decitabine regimen

    ... Decitabine has been explored as a reduced-intensity therapy for older or ... (AML). To better understand the risk of infections during decitabine treatment, we retrospectively examined the culture results from each ...

    Research Article last updated 11/08/2017 - 9:26am.

  10. Optimizing the use of hypomethylating agents in myelodysplastic syndromes: Selecting the candidate, predicting the response, and enhancing the activity

    ... hypomethylating agents (HMAs) azacitidine and decitabine are approved for use in the United States and in Europe for the ...

    Research Article last updated 10/23/2017 - 11:00am.